Zika Virus Vaccines


The live-attenuated vaccine is developed for the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, the definition of E dimers as the key antigenic target, and a deep understanding of neutralization mechanisms help to develop the vaccine.


    Related Conference of Zika Virus Vaccines

    February 20-21, 2023

    International Conference on Vaccine Research

    Madrid, Spain
    March 23-24, 2023

    6th International Conference on Vaccines, Immunology and Clinical Trials

    Amsterdam, Netherlands
    March 27-28, 2023

    International Conference on Vaccine & Vaccine Research

    San Diego, USA
    April 03-04, 2023

    6th International Conference on Vaccines and Immunology

    Paris, France
    May 22-23, 2023

    41st Euro Global Summit and Expo on Vaccines & Vaccination

    Berlin, Germany
    October 18-19, 2023

    43rd Global Summit and Expo on Vaccines & Immunology

    Vienna, Austria
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan

    Zika Virus Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in